跳至主要内容
临床试验/NCT06820294
NCT06820294Enrolling By Invitation不适用

Assessing the Clinical Benefits of Whole Genome Sequencing for Children with Neoplasms

The Wellcome Sanger Institute1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2022年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
2,000
试验地点
1
主要终点
The proportion of children clinically benefiting from whole genome sequencing

研究概览

简要总结

This retrospective case series reviews clinical notes to assess whether NHS whole genome sequencing provides tangible benefits for paediatric tumours.

详细描述

The NHSE-commissioned whole genome sequencing programme went live at the end of 2020. It remains as yet unproven, whether this whole genome sequencing programme for children with cancer can deliver tangible benefits in real-time. There is an urgent need, therefore, to assess whether children with tumours who are receiving NHS whole genome sequencing are actually benefiting from this additional assay. This is a retrospective case series. The principal methodology is that of reviewing clinical notes to assess whether children with tumours have benefited from NHSE whole genome sequencing. Apart from the contribution of our work to the scientific literature, this research will inform government on the potential benefits, or lack thereof, of the live NHSE whole genome programme and has the potential to influence policy on whether this programme should be continued.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All children and young people (up to the age of 21 years) diagnosed with a neoplastic disorder who have been offered NHSE whole genome sequencing.

排除标准

  • •Anyone not offered NHSE whole genome sequencing
  • •Individuals beyond the age of 21
  • •Individuals without a neoplastic disorder.

结局指标

主要结局

The proportion of children clinically benefiting from whole genome sequencing

时间窗: 5.5 years

The proportion of children clinically benefiting from whole genome sequencing in terms of improving diagnoses, treatment, and prognostication, amongst other aspects

次要结局

  • Relation between mutation data and disease phenotypes(5.5 years)

研究者

发起方
The Wellcome Sanger Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验